Category: Biotechnology

Abpro and China’s NJCTTQ join forces to develop bispecific antibodies

The firms will be using Abpro’s innovative DiversImmune technology for developing bispecific antibodies for immuno-oncology Abpro is reportedly teaming up with China-based NJCTTQ for developing new, innovative bispecific antibodies by deploying its antibody discovery platform. As part of the agreement, Abpro would receive up to $4 billion, which will be …

QIAGEN partners with Ares Genetics to strengthen AMR research

QIAGEN can use Ares Genetics’ Antimicrobial Resistance (AMR) database and use its expertise in bioinformatics to accelerate AMR research. QIAGEN N.V., the Netherlands-based provider of Sample to Insight solutions recently announced that it has signed a broad agreement with Ares Genetics that specializes in infectious disease diagnostics and therapeutics, to …

Innovent Biologics initiates Phase I clinical trial of IBI101

The clinical study is meant to evaluate the primary efficacy, tolerance and safety of IBI101. Innovent Biologics, Inc., a China based, global biopharmaceutical company that specializes in development, manufacturing and commercialization of superior quality innovative medicines for cancer, immunotherapy and other diseases, recently announced that it will be initiating its …

Cartherics & panCELLa collaborate to develop safe cell therapy

panCELLa welcomed Cartherics as a capable partner in the addressing of needs of cancer patients treated with immunotherapy. Cartherics Pty Ltd, the pluripotent stem cell technology developing Australian company and the Canada based panCELLa Inc, an early-stage biotechnology company, recently announced that they will be collaborating on the research and …

Kuros Biosciences inks new bone graft supply agreement with SeaSpine

The agreement showcases the interest of prominent orthobiologic firms in Kuros technologies. The global partner would be responsible for marketing an advanced bone graft that would be supplied by Kuros. Kuros Biosciences (Kuros), a renowned Swiss biotechnology company, has reportedly announced that the company’s Dutch subsidiary has entered into an Original …

Precision For Medicine buys ApoCell to expand biomarker capabilities

Precision for Medicine has announced the acquisition of ApoCell, a Houston-based next-generation lab that specializes in the identification and analysis of biomarkers. By acquiring ApoCell, its ApoStream® liquid biopsy technology and extensive tissue profiling expertise will be added to Precision’s strong portfolio of specialty laboratory and biomarker informatics services. The …

ImaginAb signs a multi-year licensing collaboration deal with Merck

ImaginAb, a California based immune and oncology imaging firm, has reportedly announced that it has signed a non-exclusive multi-year licensing collaboration with the New Jersey-based pharmaceutical company Merck & Company, Inc. As per the deal, Merck & Company, also known as Merck Sharp & Dohme (MSD) outside of Canada and …

Ipsen joins BIO to promote research and innovation in biotechnology

Ipsen, the French pharmaceutical company recently announced that it has joined the Biotechnology Innovation Organization, known for being the world’s largest organization representing the biotechnology industry including biotech centers and academic institutions. Ipsen has joined the global community in an attempt to improve patient experience as well as to propel …